Wondering whether Recursion Pharmaceuticals at around US$3.39 is a bargain or a value trap? This article focuses squarely on what the current share price might be telling you about the business. The ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to invest in now. On April ...

OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.

Recursion (NASDAQ: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Chris Gibson ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its first quarter 2026 ...

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...

Ineffable Intelligence, a British AI lab founded a mere few months ago by former DeepMind researcher David Silver, has raised ...

Penn Engineers have developed a new way to use AI to solve inverse partial differential equations (PDEs), a particularly ...

Altitude Labs, an offshoot of AI-focused techbio Recursion, is teaching scientists to build companies, one founder at a time.

Former employees at AI giants are raising hundreds of millions of dollars from investors months on from launching.

A former top researcher at Google AI division DeepMind announced Monday a record $1.1 billion seed round for his months-old ...

Digital transformation has created vast new opportunities. But that didn’t mean getting rid of everything we already had.